Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0171 per EA under NDC 64980065710. Its NADAC has been published 58 times since Aug 27, 2025.
FDA first approved this application on Sep 12, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980065710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218936FDA Approved
9/12/2024
TE Code
AB
On Market Since
2/19/2025
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 58 times since Aug 27, 2025, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0171 per EA |
|---|---|
| All-time high | $0.0192 (Sep 10, 2025) |
| All-time low | $0.0169 (Aug 19, 2026) |
| 52-week high | $0.0190 |
| 52-week low | $0.0169 |
| Median price | $0.0178 |
| Average price | $0.0179 |
| Largest weekly change | -2.7% (Oct 22, 2025) |
| Weeks tracked | 58 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclobenzaprine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0171 per EA (NDC 64980065710), effective Sep 30, 2026.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 10.6%. It has been tracked across 58 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Aug 27, 2025, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0169 (Aug 19, 2026) to a high of $0.0192 (Sep 10, 2025), with a median of $0.0178 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 64980065710) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.